If you could vote on Brexit now which option would you choose?

J&J booster slashes Omicron hospitalisations -S.African study

A booster dose of Johnson & Johnson Inc's (JNJ.N) single-dose COVID-19 vaccine was 84% effective at preventing hospitalisation in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday. The real-world study, which has not been peer-reviewed, was based on a second dose of the J&J vaccine administered to 69,092 workers between Nov. 15 and Dec. 20.

Reuters - December 31, 2021

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-booster-84-effective-against-hospitalization-safrican-omicron-era-study-2021-12-30/